Editorial: Myeloid-derived suppressor cells: a new therapeutic target in sepsis patients
J Leukoc Biol
.
2017 Aug;102(2):185-187.
doi: 10.1189/jlb.5CE0317-080R.
Authors
Julie A Stortz
1
,
Philip A Efron
2
Affiliations
1
Department of Surgery, University of Florida College of Medicine, Gainesville, Florida, USA.
2
Department of Surgery, University of Florida College of Medicine, Gainesville, Florida, USA philip.efron@surgery.ufl.edu.
PMID:
28765508
DOI:
10.1189/jlb.5CE0317-080R
No abstract available
Keywords:
immunosuppression; inflammation; microRNA; myelopoiesis.
Publication types
Editorial
Research Support, N.I.H., Extramural
Comment
MeSH terms
Humans
Myeloid Cells
Myeloid-Derived Suppressor Cells*
Myelopoiesis
Sepsis*
Grants and funding
R01 GM113945/GM/NIGMS NIH HHS/United States
T32 GM008721/GM/NIGMS NIH HHS/United States
P30 AG028740/AG/NIA NIH HHS/United States
P50 GM111152/GM/NIGMS NIH HHS/United States
R01 GM040586/GM/NIGMS NIH HHS/United States